Latest Breaking News On - Urogen pharma - Page 1 : vimarsana.com

UroGen Pharma (NASDAQ:URGN) PT Lowered to $32 00 at Oppenheimer

UroGen Pharma (NASDAQ:URGN – Free Report) had its price target cut by Oppenheimer from $34.00 to $32.00 in a research report sent to investors on Tuesday, Benzinga reports. They currently have an outperform rating on the stock. Separately, HC Wainwright reaffirmed a buy rating and set a $54.00 target price on shares of UroGen Pharma […]

Urogen pharmaMark schoenbergUrogen pharma ltdConnor clark lunn investment management ltdChina universal asset management coAllspring global investments holdingsJump financialSecurities exchange commissionFree reportGen pharma trading downGen pharmaGet free reportExchange commissionGlobal investments holdingsUniversal asset managementFinancial markets

UroGen Pharma First Quarter 2024 Earnings: Misses Expectations

UroGen Pharma First Quarter 2024 Earnings: Misses Expectations
yahoo.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from yahoo.com Daily Mail and Mail on Sunday newspapers.

Urogen pharmaGen pharma revenuesEarnings miss

UroGen Pharma Ltd (NASDAQ:URGN) Q1 2024 Earnings Call Transcript

UroGen Pharma Ltd (NASDAQ:URGN) Q1 2024 Earnings Call Transcript
insidermonkey.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from insidermonkey.com Daily Mail and Mail on Sunday newspapers.

San antonioUnited statesPaul choiWilliam huangElizabeth barrettMatt kaplanVincent perroneMark schoenbergDon kimTara bancroftJeff bovaRaghuram selvarajuLiz barrettLeland gershellUrogen pharma ltdLadenburg thalmann

UroGen Pharma Announces Date for ENVISION Data, New Long-Term Jelmyto Durability Data, and Reports 2024 First Quarter Financial Results and Business Highlights

UroGen Pharma Announces Date for ENVISION Data, New Long-Term Jelmyto Durability Data, and Reports 2024 First Quarter Financial Results and Business Highlights
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

San antonioUnited statesUrogen pharmaLiz barrettUrogen rtgelDrug administrationAmerican urological associationUrogen pharma ltdCompany investigational new drugChief executive officerRecent business highlightsNew drug applicationInvestigational new drugPrepaid forward obligationLong term debtPharmakon advisors

URGN Stock Earnings: UroGen Pharma Misses EPS, Misses Revenue for Q1 2024

URGN Stock Earnings: UroGen Pharma Misses EPS, Misses Revenue for Q1 2024
biztoc.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biztoc.com Daily Mail and Mail on Sunday newspapers.

Urogen pharmaMarket newsStock adviceUrogen pharma missesMisses revenue